Phathom Pharmaceuticals, Inc. (PHAT)
Market Closed
26 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
5. 94
+0.2
+3.4843%
After Hours
$
+0.14 +2.3569% 6. 08
559.83M Market Cap
- P/E Ratio
- Div Yield
2.11M Volume
-4.59 Eps
$ 5.74
Previous Close Want to track PHAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Phathom Pharmaceuticals, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 SummitTX Capital LP SummitTX Capital LP | 789,550 | $9.61M | $4.63M | -$4.99M | -51.87% |
 Meriwether Wealth & Planning LLC Meriwether Wealth & Planning LLC | 250 | $1,825 | $1,307.5 | -$517.5 | -28.36% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 47,663 | $594,882.09 | $277,636.97 | -$317,245.12 | -53.33% |
 GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 1,669 | $13,761.61 | $9,204.53 | -$4,557.08 | -33.11% |
2026 © Marketlog. All Rights Reserved.
